[Policy Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023 (May 24, 2023)
date : 6/7/2023
Tags: AMR
On May 24, 2023, AMR Alliance Japan (Secretariat: Health and Global Policy Institute) released “Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” to promote infectious disease control measures to combat antimicrobial resistance (AMR). The content of the recommendations was as follows.
Promote countermeasures for antimicrobial resistance (AMR) with a One Health approach from perspectives including economic security and serve as a global leader in strengthening preparedness against the threat of infectious disease.
Every year since 2016, Japan’s Basic Policies on Economic and Fiscal Management and Reform have mentioned strengthening efforts to promote AMR control and expanding systems for research, testing, and treatment. Mention of this objective was expanded in 2022 to state, “Japan will also comprehensively examine concrete methods to secure therapeutic drugs for drug-resistant bacteria such as market incentives in measures designed to counter drug resistance, draw conclusions based on these examinations, and then play a leading role in international discussions.” In this manner, Japan has emphasized the importance of AMR control.
As described in the attachment titled, “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background,” progress is being made in measures to combat AMR both in Japan and around the world. Looking ahead to the 79th session of the UN General Assembly (UNGA 79) in 2024 and beyond, it will be crucial for Japan to fulfill its commitments to the international community in its capacity as G7 President in 2023 based on the idea that infectious disease control cannot be fully implemented by countries acting alone.
“Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023” and “Promoting Antimicrobial Resistance (AMR) Countermeasures in the Basic Policy on Economic and Fiscal Management and Reform 2023 Recommendation Background” can be found here.
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



